Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Delineating Drug Class and Target-Specific Adverse Events of Kinase Inhibitors

Annalise Schweickart, Juhi Somani, Ryan Theisen, Navriti Sahni, Anna Cichońska, Rayees Rahman
doi: https://doi.org/10.1101/2024.08.07.24311573
Annalise Schweickart
1Harmonic Discovery Inc.; New York, NY, 10013, USA
2Department of Physiology and Biophysics, Weill Cornell Medicine; New York, NY, 10021, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juhi Somani
1Harmonic Discovery Inc.; New York, NY, 10013, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan Theisen
1Harmonic Discovery Inc.; New York, NY, 10013, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Navriti Sahni
1Harmonic Discovery Inc.; New York, NY, 10013, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Cichońska
1Harmonic Discovery Inc.; New York, NY, 10013, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anna{at}harmonicdiscovery.com rayees{at}harmonicdiscovery.com
Rayees Rahman
1Harmonic Discovery Inc.; New York, NY, 10013, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anna{at}harmonicdiscovery.com rayees{at}harmonicdiscovery.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2024.08.07.24311573
History 
  • August 8, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Annalise Schweickart1,2,
  2. Juhi Somani1,
  3. Ryan Theisen1,
  4. Navriti Sahni1,
  5. Anna Cichońska1,* and
  6. Rayees Rahman1,*
  1. 1Harmonic Discovery Inc.; New York, NY, 10013, USA
  2. 2Department of Physiology and Biophysics, Weill Cornell Medicine; New York, NY, 10021, USA
  1. ↵*Corresponding author: Email: anna{at}harmonicdiscovery.com, rayees{at}harmonicdiscovery.com
Back to top
PreviousNext
Posted August 08, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Delineating Drug Class and Target-Specific Adverse Events of Kinase Inhibitors
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Delineating Drug Class and Target-Specific Adverse Events of Kinase Inhibitors
Annalise Schweickart, Juhi Somani, Ryan Theisen, Navriti Sahni, Anna Cichońska, Rayees Rahman
medRxiv 2024.08.07.24311573; doi: https://doi.org/10.1101/2024.08.07.24311573
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Delineating Drug Class and Target-Specific Adverse Events of Kinase Inhibitors
Annalise Schweickart, Juhi Somani, Ryan Theisen, Navriti Sahni, Anna Cichońska, Rayees Rahman
medRxiv 2024.08.07.24311573; doi: https://doi.org/10.1101/2024.08.07.24311573

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pharmacology and Therapeutics
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)